Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2009
08/19/2009CN101507727A Traditional Chinese medicine composite capable of reducing blood fat and preparation method thereof
08/19/2009CN101507726A Association of a sinus If current inhibitor and a beta blocker
08/19/2009CN101507725A Use of stephanine and hydrochloride thereof in preparing anti-hepatitis virus medicine
08/19/2009CN101507724A Use of pyrroloquinoline quinine in antiradiation
08/19/2009CN101507723A Combination medicine capable of treating pneumonia and upper respiratory tract infection and preparation method thereof
08/19/2009CN101507722A Combination for treating coronary heart disease angina
08/19/2009CN101507721A Postprandial hyperglycemia-improving agent
08/19/2009CN101507720A Methods of modulating angiogenesis and cancer cell proliferation
08/19/2009CN101507719A Vitamin C film-coat preparation and preparation method thereof
08/19/2009CN101507718A Sodium rabeprazole enteric-coated orally disintegrating tablets and preparation method thereof
08/19/2009CN101507716A Nifedipine sustained-release preparation and preparation method thereof
08/19/2009CN101507715A Solid preparation of angiotensin receptor inhibitor and amlodipine and new preparation method thereof
08/19/2009CN101507714A Oral preparation containing 7,9-dihydroxy-15-carbonyl-16-kaurene -19,6-lactone
08/19/2009CN101507713A High bioavailability proton pump inhibitor sustained-release technique
08/19/2009CN101507711A Ligustrazine micro-spheres and preparation method thereof
08/19/2009CN101507708A Preparation method of liposome
08/19/2009CN101507707A Fasudil hydrochloride lipo-microballoons carrier preparation and preparation method thereof
08/19/2009CN101507706A Biodegradable in-situ solidification sustained-release injector
08/19/2009CN101507705A Preparation method of block polymer micelle administration system with targeting effect
08/19/2009CN101507704A Lutein solid dispersoid and preparation method thereof
08/19/2009CN100530742C Method of doping organic semiconductors with quinonediimine derivatives
08/19/2009CN100530268C Exercise support instrument
08/19/2009CN100529759C Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
08/19/2009CN100529043C Ampelopsin healthcare wine
08/19/2009CN100528933C Calcium polyaspartate and preparation method thereof
08/19/2009CN100528901C Method for separating polysaccharide against growth of cancer cells from dictyophord
08/19/2009CN100528894C 15-(14-deoxy 11,12 dehydro) andrographolide carbonic side derivate and preparation process thereof
08/19/2009CN100528889C 1-0-caffeoyl -6-0-(S)-caesalpinia sepiaria acyl group -Beta-D-glucopyranose and uses thereof
08/19/2009CN100528888C Novel anticonvulsant derivative salts
08/19/2009CN100528886C Metal complex with liriodenine as ligand and its synthesis process and use
08/19/2009CN100528884C Phosphor isoquinolinone, derivative, synthesis method and use thereof
08/19/2009CN100528879C S type 4-substituted hydroxy-pyranindolelidinyl compounds and its derivatives and production method
08/19/2009CN100528878C Tetrahydroquinoline derivatives and a process for preparing the same
08/19/2009CN100528877C New purine alkaloid and preparation method and application thereof
08/19/2009CN100528876C Pyrrazolo-pyrimidine derivatives
08/19/2009CN100528875C Crystal-free type Idi prone and its preparing method
08/19/2009CN100528874C Pyrrolo [2,3d] pyrimidine compositions and their use
08/19/2009CN100528872C Tetrahydro-proto-berberine compounds, their preparing method, composition and use
08/19/2009CN100528871C Benzothiazole derivatives as adenosine receptor ligands
08/19/2009CN100528870C Internal ester monomer compound and its application in preparing anti cancer medicine
08/19/2009CN100528869C Silybin flavonolignan and their production method and use
08/19/2009CN100528866C Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
08/19/2009CN100528864C N-substituted-2-oxodihydropyridine derivative
08/19/2009CN100528850C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
08/19/2009CN100528849C Process for the preparation of 1,2-dichloroethane free crystals of zonisamide and high pure crystals of zonisamide
08/19/2009CN100528844C Huperzine A derivative, preparation method and application thereof
08/19/2009CN100528842C Diphenylazetidinone derivatives for treating disorders of the lipid metabolism
08/19/2009CN100528841C Sulfonamide compound
08/19/2009CN100528835C Crystalline form of beta2 adrenergic receptor agonist
08/19/2009CN100528834C Pharmaceutical compounds
08/19/2009CN100528824C Beta-elemene monosubstituted ether derivatives, synthesis method and use thereof
08/19/2009CN100528326C Method for preparing anti-oxidant bio-microcapsule
08/19/2009CN100528318C Granules comprising a beta-lactam antibiotic
08/19/2009CN100528264C Health gauze mask
08/19/2009CN100528237C Preparation of polynuclear iron hydroxide-sugar composite
08/19/2009CN100528234C Lactobionic acid azithromycin for injections and preparation method thereof
08/19/2009CN100528233C Process for producing coated preparation having relieved unpleasantness
08/19/2009CN100528232C Pharmaceutical preparation in form of suspension comprising acid-labile active ingredient
08/19/2009CN100528231C Anti-inflammatory and antimicrobial uses for bioactive glass compositions
08/19/2009CN100528217C Effective germinal liquid
08/19/2009CN100528214C Capsule for treating epilepsia and its preparing method
08/19/2009CN100528195C Preparation of dyers woad root injection
08/19/2009CN100528194C Medicine for treating femoral head necrosis
08/19/2009CN100528188C Chinese traditional medicinal anesthetics
08/19/2009CN100528183C Capsule for treating gout
08/19/2009CN100528177C Red yeast preparation containing active components of glossy ganoderma and its preparation process
08/19/2009CN100528176C Chinese traditional medicinal composition for treating acne
08/19/2009CN100528174C Combination of cytidine disodium triphosphate and arginine, and preparation method thereof
08/19/2009CN100528173C 4'-substituted nucleosides
08/19/2009CN100528172C Oral medicine for treating turtle parotiditis
08/19/2009CN100528171C Oil-in-water baicalin nano-milk oral liquid and its preparing process
08/19/2009CN100528170C Mangiferin preparation and production thereof
08/19/2009CN100528169C Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
08/19/2009CN100528168C 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
08/19/2009CN100528167C Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
08/19/2009CN100528166C Portal hypertension inhibitor
08/19/2009CN100528165C Stable medicine composition of setastine or its salt
08/19/2009CN100528164C Statin therapy for enhancing cognitive maintenance
08/19/2009CN100528163C Oral cavity disintegration tablet for treating gout and its preparation method
08/19/2009CN100528162C Pharmaceutical compositions
08/19/2009CN100528161C Medicinal composition
08/19/2009CN100528160C An antibacterial rifampicin nanoemulsion and preparation method thereof
08/19/2009CN100528159C Nicotinic receptor agonists for treatment of inflammatory diseases
08/19/2009CN100528158C Pharmaceutical composition for oral administration of a pyrazol-3-carboxamide derivative
08/19/2009CN100528157C Form of presentation for 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester to be administered oral
08/19/2009CN100528156C Prevention of addiction in pain management
08/19/2009CN100528155C Nanometer berberine hydrochloride emulsion and its preparation process
08/19/2009CN100528154C Malonyl-COA decarboxylase inhibitors useful as metabolic modulators
08/19/2009CN100528153C Percutaneous absorption type cerebral protective agent
08/19/2009CN100528152C 5-hydroxymethyl -2-furol and its derivative analogue medical use
08/19/2009CN100528151C Pharmaceutical formulations of modafinil
08/19/2009CN100528150C Novel pharmaceutical formulations of modafinil
08/19/2009CN100528149C A composition for treating neurocerebrovascular disorders
08/19/2009CN100528148C Oil-in-water type nanometer peonol emulsion oral liquid and its preparation process
08/19/2009CN100528144C Aceclofenac in extended-released tablets and method of manufacturing the same
08/19/2009CN100528141C Freeze dried ligustrazine hydrochloride preparation for injection and its preparation process
08/19/2009CN100528140C Stable shaped particles of crystalline organic compounds and preparation method thereof
08/19/2009CN100528139C Preserved ophthalmic compositions
08/18/2009USRE40876 Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagonlike peptide-1 and agonists thereof
08/18/2009US7576241 e.g. 2-hydroxy-5-methoxy-N-{2-[4-[(2-thienyl(imino)methyl)amino]phenyl]ethyl)}-benzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent